Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus

Significant effects of DJBL treatment on NAFLD fibrosis and APRI score further suggests protective effects of DJBL on liver-related morbidity and mortality in patients with obesity and T2DM.

https://www.sciencedirect.com/science/article/abs/pii/S0899900722002192

Morphic Medical, Inc.
320 Congress Street
3rd Floor
Boston, MA 02210

Home
RESET@
Clinical Trials
Terms of Use
Privacy Policy
Cookie Policy
Patents
Copyright

Name

Message

RESET® is approved for sale in the European Union. In the United States RESET® is limited to Investigational Use Only.
©2024 Morphic Medical, Inc. All Rights Reserved.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Necessary

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled